Advil-maker Haleon boosts sales by targeting consumers on weight-loss drugs
Advil maker Haleon is capitalizing on the GLP-1 boom, boosting sales of products that combat weight loss drugs side effects with strategic store placement.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.